These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 7971977

  • 41. Ethanol sensitivity of heteromeric NMDA receptors: effects of subunit assembly, glycine and NMDAR1 Mg(2+)-insensitive mutants.
    Mirshahi T, Woodward JJ.
    Neuropharmacology; 1995 Mar; 34(3):347-55. PubMed ID: 7630488
    [Abstract] [Full Text] [Related]

  • 42. NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A.
    Goebel DJ, Poosch MS.
    Brain Res Mol Brain Res; 1999 Jun 08; 69(2):164-70. PubMed ID: 10366738
    [Abstract] [Full Text] [Related]

  • 43. The NR3B subunit does not alter the anesthetic sensitivities of recombinant N-methyl-D-aspartate receptors.
    Yamakura T, Askalany AR, Petrenko AB, Kohno T, Baba H, Sakimura K.
    Anesth Analg; 2005 Jun 08; 100(6):1687-1692. PubMed ID: 15920196
    [Abstract] [Full Text] [Related]

  • 44. A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.
    Brimecombe JC, Potthoff WK, Aizenman E.
    J Pharmacol Exp Ther; 1999 Nov 08; 291(2):785-92. PubMed ID: 10525101
    [Abstract] [Full Text] [Related]

  • 45. Relationship between N-methyl-D-aspartate receptor NR1 splice variants and NR2 subunits.
    Blahos J, Wenthold RJ.
    J Biol Chem; 1996 Jun 28; 271(26):15669-74. PubMed ID: 8663041
    [Abstract] [Full Text] [Related]

  • 46. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.
    Hollmann MW, Liu HT, Hoenemann CW, Liu WH, Durieux ME.
    Anesth Analg; 2001 May 28; 92(5):1182-91. PubMed ID: 11323344
    [Abstract] [Full Text] [Related]

  • 47. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors.
    Williams K.
    Neurosci Lett; 1996 Aug 30; 215(1):9-12. PubMed ID: 8880741
    [Abstract] [Full Text] [Related]

  • 48. Cloning, functional coexpression, and pharmacological characterisation of human cDNAs encoding NMDA receptor NR1 and NR2A subunits.
    Le Bourdellès B, Wafford KA, Kemp JA, Marshall G, Bain C, Wilcox AS, Sikela JM, Whiting PJ.
    J Neurochem; 1994 Jun 30; 62(6):2091-8. PubMed ID: 8189218
    [Abstract] [Full Text] [Related]

  • 49. Glycine-independent and subunit-specific potentiation of NMDA responses by extracellular Mg2+.
    Paoletti P, Neyton J, Ascher P.
    Neuron; 1995 Nov 30; 15(5):1109-20. PubMed ID: 7576654
    [Abstract] [Full Text] [Related]

  • 50. Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors.
    Dravid SM, Burger PB, Prakash A, Geballe MT, Yadav R, Le P, Vellano K, Snyder JP, Traynelis SF.
    J Neurosci; 2010 Feb 17; 30(7):2741-54. PubMed ID: 20164358
    [Abstract] [Full Text] [Related]

  • 51. Pharmacological and immunological characterization of N-methyl-D-aspartate receptors in human NT2-N neurons.
    Munir M, Lu L, Wang YH, Luo J, Wolfe BB, McGonigle P.
    J Pharmacol Exp Ther; 1996 Feb 17; 276(2):819-28. PubMed ID: 8632355
    [Abstract] [Full Text] [Related]

  • 52. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
    Masuko T, Suzuki T, Miyake M, Kusama-Eguchi K, Kizawa Y, Tomono K, Kashiwagi K, Igarashi K, Kusama T.
    Neurosci Lett; 2012 Jan 11; 506(2):251-5. PubMed ID: 22119002
    [Abstract] [Full Text] [Related]

  • 53. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA, Chen PE, Wyllie DJ.
    Mol Pharmacol; 2006 Sep 11; 70(3):1022-32. PubMed ID: 16778008
    [Abstract] [Full Text] [Related]

  • 54. Hippocampal NMDA receptor mRNA undergoes subunit specific changes during developmental lead exposure.
    Guilarte TR, McGlothan JL.
    Brain Res; 1998 Apr 20; 790(1-2):98-107. PubMed ID: 9593842
    [Abstract] [Full Text] [Related]

  • 55. Molecular determinants of multiple effects of nickel on NMDA receptor channels.
    Gavazzo P, Guida P, Zanardi I, Marchetti C.
    Neurotox Res; 2009 Jan 20; 15(1):38-48. PubMed ID: 19384586
    [Abstract] [Full Text] [Related]

  • 56. Characterization in cultured cerebellar granule cells and in the developing rat brain of mRNA variants for the NMDA receptor 2C subunit.
    Rafiki A, Bernard A, Medina I, Gozlan H, Khrestchatisky M.
    J Neurochem; 2000 May 20; 74(5):1798-808. PubMed ID: 10800922
    [Abstract] [Full Text] [Related]

  • 57. Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly.
    Schüler T, Mesic I, Madry C, Bartholomäus I, Laube B.
    J Biol Chem; 2008 Jan 04; 283(1):37-46. PubMed ID: 17959602
    [Abstract] [Full Text] [Related]

  • 58. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
    Kashiwagi K, Fukuchi J, Chao J, Igarashi K, Williams K.
    Mol Pharmacol; 1996 Jun 04; 49(6):1131-41. PubMed ID: 8649353
    [Abstract] [Full Text] [Related]

  • 59. Molecular evidence for the involvement of NR2B subunit containing N-methyl-D-aspartate receptors in the development of morphine-induced place preference.
    Narita M, Aoki T, Suzuki T.
    Neuroscience; 2000 Jun 04; 101(3):601-6. PubMed ID: 11113309
    [Abstract] [Full Text] [Related]

  • 60. A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons.
    Kostakis E, Jang MK, Russek SJ, Gibbs TT, Farb DH.
    J Neurochem; 2011 Nov 04; 119(3):486-96. PubMed ID: 21883211
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.